If it is not J&J, that means they did not exercise their ROFR and another ophthalmolic industry leader has latched onto them. It is most likely J&J Imo, which would be absolutely awesome.
Actually, it is awesome that any multibillion-dollar leader is now pursuing prototype production involving $EPGL's patents. I mean, this is what we've been waiting for, isn't it? Go $EPGL!
Also, don't forget... more patents on the way!